OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Eliav Shaked

2 Projects | 1 Researchers | $645,000 Invested

2019

RetiSpec Inc.

Eliav Shaked, MSc

Retinal Changes in Alzheimer’s disease (AD) Correlated with Cerebral Amyloid Staging, A Promising Early Biomarker in AD

  • Funding Amount: $375,000
  • Organization Type: Biotechnology/For Profit
  • Program: Biomarkers
  • Target: zzAbeta
  • Status: Closed